Primary tabs
Please join the Cambridge Alliance on Medicines Safety (CAMS) for an exciting afternoon of Talks on the ‘Safety of emerging Advanced Therapies’ in oncology treatment, focusing on immunotherapeutic approaches. We will be diving into the clinical landscape of immune checkpoint inhibitors and their associated clinical risks with members of the Immuno-Oncology toxicity working group at Cambridge University Hospitals, and exploring the emerging safety risks of cell therapies, from bench to bedside, with speakers from AstraZeneca and Academia.
This event takes place on Thursday 6th March at the Theo Chalmers Lecture Theatre, School of Clinical Medicine (1-5pm). Please register for this event via EventBrite. (https://www.eventbrite.co.uk/e/1244835920749?aff=oddtdtcreator).
